Citation Impact
Citing Papers
Prophylactic Lymph Node Dissection for Papillary Thyroid Cancer Less Than 2 cm: Implications for Radioiodine Treatment
2008
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Pharmaceutical Particle Engineering via Spray Drying
2007 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Prediction of lateral lymph node metastases in medullary thyroid cancer
2008
Current approaches to medullary thyroid carcinoma, sporadic and familial
2006
Prognostic Impact of Serum Calcitonin and Carcinoembryonic Antigen Doubling-Times in Patients with Medullary Thyroid Carcinoma
2005
Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)
2007 Standout
Novel radiolabeled antibody conjugates
2007
A New Hot Spot for Mutations in theretProtooncogene Causing Familial Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2A1
1998
Genotype-phenotype correlations in Hungarian patients with hereditary medullary thyroid cancer
2006
Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies
2008
A Cys634Gly substitution of the RET proto‐oncogene in a family with recurrence of multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis
1997
Peak Incidence of Pheochromocytoma and Primary Hyperparathyroidism in Multiple Endocrine Neoplasia 2: Need for Age-Adjusted Biochemical Screening
2013
Prognostic Factors in Well-Differentiated Follicular-Derived Carcinoma and Medullary Thyroid Carcinoma
2001
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
1997 Standout
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Thyroid cancer
2016 Standout
Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma
2005
Gastrointestinal dysfunction in Parkinson's disease
2003 Standout
The clinicopathological significance of histologic vascular invasion in differentiated thyroid carcinoma
2002
Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocality
2003 Standout
Biological Relevance of Medullary Thyroid Microcarcinoma
2012
ESPEN guideline: Clinical nutrition in surgery
2017 Standout
The von Hippel–Lindau Tumor Suppressor Gene
2001 StandoutNobel
Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients
2004
RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan
2004
Familial medullary thyroid carcinoma: Not a distinct entity? Genotype-phenotype correlation in a large family
1996
Réintervention pour carcinome médullaire de la thyroïde : résultats à long terme
2001
Novel point mutation in exon 10 of theRET proto-oncogene in a family with medullary thyroid carcinoma
1998
Two Germline Missense Mutations at Codons 804 and 806 of the RET Proto‐oncogene in the Same Allele in a Patient with Multiple Endocrine Neoplasia Type 2B without Codon 918 Mutation
1999
Molecular basis of the VHL hereditary cancer syndrome
2002 StandoutNobel
Post-Transplant Diabetes Mellitus The Role of Immunosuppression
1997
Cushing's syndrome
2015 Standout
Nomograms in oncology: more than meets the eye
2015 Standout
The Genetic Basis of Pheochromocytoma
2003
Cancer Statistics, 2006
2006 Standout
Defects in enteric innervation and kidney development in mice lacking GDNF
1996 StandoutNature
A Two-Hit Model for Development of Multiple Endocrine Neoplasia Type 2B by RET Mutations
2000
Nine Novel Germline Gene Variants in the RET Proto-Oncogene Identified in Twelve Unrelated Cases
2005
Long‐term prognosis of medullary thyroid carcinoma
2008
Failure to Recognize Multiple Endocrine Neoplasia 2B: More Common Than We Think?
2007
Management of hereditary medullary thyroid carcinoma
2016
Medullary Thyroid Carcinoma
2007
Presentation of a kindred with familial medullary thyroid carcinoma and Cys611Phe mutation of the RET proto-oncogene demonstrating low grade malignancy
2001
Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma
2001 Standout
von Hippel-Lindau Disease
1997 StandoutNobel
Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto‐oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal
2006
Prospects of Remission in Medullary Thyroid Carcinoma According to Basal Calcitonin Level
2005
A Novel Point Mutation in the Intracellular Domain of theretProtooncogene in a Family with Medullary Thyroid Carcinoma1
1997
Embolization of Hepatic and Adrenal Metastasis to Treat Cushing’s Syndrome Associated with Medullary Thyroid Carcinoma: A Case Report
2007
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism
2016 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
RET mutations in human disease
1996
Germ line mutation analysis in families with multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma
1998
The Timing of Total Thyroidectomy in RET Gene Mutation Carriers Could Be Personalized and Safely Planned on the Basis of Serum Calcitonin: 18 Years Experience at One Single Center
2011
Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein
1999 StandoutNobel
A Novel Somatic Mutation in the RET Proto‐oncogene in Familial Medullary Thyroid Carcinoma with a Germline Codon 768 Mutation
1997
The Diagnosis and Work-up of the Patient With Gastroparesis
2000
von Hippel-Lindau disease
2003 Standout
TheRETProto-Oncogene in Multiple Endocrine Neoplasia Type 2 and Hirschsprung's Disease
1996
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
Advances in the management of hereditary medullary thyroid cancer
2004
Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome
2001
Multimodal Imaging Analysis of Tumor Progression and Bone Resorption in a Murine Cancer Model
2006
LOW INCIDENCE OF KIDNEY REJECTION AFTER SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION AFTER ANTITHYMOCYTE GLOBULIN INDUCTION AND IN THE ABSENCE OF CORTICOSTEROIDS: RESULTS OF A PROSPECTIVE PILOT STUDY IN 28 CONSECUTIVE CASES
2000
Mutation of RET codon 768 is associated with the FMTC phenotype
1997
cAMP/PKA signaling defects in tumors: Genetics and tissue-specific pluripotential cell-derived lesions in human and mouse
2013
The [13C]acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals
1995
When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?
2003
Insulin Analogues
2005
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Mutations of theRET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease
1997
Prognostic Factors Associated with the Survival of Patients Developing Loco-Regional Recurrences of Differentiated Thyroid Carcinomas
2004
RET proto-oncogene mutations affecting codon 790/791: A mild form of multiple endocrine neoplasia type 2A syndrome?
2002
Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study
2001
Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a
2005
Postoperative Complications After Prophylactic Thyroidectomy for Very Young Patients With Multiple Endocrine Neoplasia Type 2
2015
Rationale for Central and Bilateral Lymph Node Dissection in Sporadic and Hereditary Medullary Thyroid Cancer
2003
Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility
2010 StandoutNobel
Sonographically‐Directed Neck Dissection for Recurrent Thyroid Carcinoma
2008
A Novel Point Mutation of theRETProtooncogene Involving the Second Intracellular Tyrosine Kinase Domain in a Family with Medullary Thyroid Carcinoma
2004
Occurrence of MEN 2a in familial hirschsprung's disease: A new indication for genetic testing of the RET proto-oncogene
1998
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
2006 Standout
Selective Activation of Somatostatin Receptor Subtypes Differentially Modulates Secretion and Viability in Human Medullary Thyroid Carcinoma Primary Cultures: Potential Clinical Perspectives
2006
Hirschsprung Disease in MEN 2A: Increased Spectrum of RET Exon 10 Genotypes and Strong Genotype--Phenotype Correlation
1998
Loss of Heterozygosity at theRETProtooncogene Locus in a Case of Multiple Endocrine Neoplasia Type 2A1
2001
Contralateral cervical and mediastinal lymph node metastasis in medullary thyroid cancer: Systemic disease?
2005
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
ISLET CELL DAMAGE ASSOCIATED WITH TACROLIMUS AND CYCLOSPORINE: MORPHOLOGICAL FEATURES IN PANCREAS ALLOGRAFT BIOPSIES AND CLINICAL CORRELATION1
1999
Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL
1997
Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia Type 2A
2005
Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen
2000 Standout
Management of medullary thyroid carcinoma and MEN2 syndromes in childhood
2011
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study
2001 Standout
Determinants of life expectancy in medullary thyroid cancer: age does not matter
2006
Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndromes in Hungary
2001
Multiple endocrine neoplasia type 2 andRET: from neoplasia to neurogenesis
2000
A census of human cancer genes
2004 Standout
Advances in the follow-up of differentiated or medullary thyroid cancer
2012
Very early detection of RET proto‐oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children
2002
Management of Well-Differentiated Thyroid Cancer in 2010: Perspectives of a Head and Neck Surgical Oncologist
2010
Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and/or Krebs cycle defects?
2012
Multiple endocrine neoplasia type 2 and the RET protooncogene: From bedside to bench to bedside
2005
Prophylactic thyroidectomy in multiple endocrine neoplasia: the impact of molecular mechanisms of RET proto-oncogene
2003
Prognosis of medullary thyroid carcinoma
2006
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Update on the MEN 2A c804 RET mutation: Is prophylactic thyroidectomy indicated?
2000
Gastric emptying, glucose metabolism and gut hormones: Evaluation of a common preoperative carbohydrate beverage
2011
The RET Mutation E768D Confers a Late-onset Familial Medullary Thyroid Carcinoma – Only Phenotype with Incomplete Penetrance: Implications for Screening and Management of Carrier Status
2006
The VHL tumour-suppressor gene paradigm
1998 StandoutNobel
Familial Medullary Thyroid Carcinoma with Noncysteine RET Mutations: Phenotype-Genotype Relationship in a Large Series of Patients
2001
Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre
2006
Exon 5 of the RET proto-oncogene: A newly detected risk exon for familial medullary thyroid carcinoma, a novel germ-line mutation Gly321Arg
2005
A NovelVal648IleSubstitution inRETProtooncogene Observed in aCys634ArgMultiple Endocrine Neoplasia Type 2A Kindred Presenting with an Adrenocorticotropin-Producing Pheochromocytoma
2002
Genotype-Phenotype Correlations in Hereditary Medullary Thyroid Carcinoma: Oncological Features and Biochemical Properties1
2001
Early Onset of Medullary Thyroid Carcinoma in a Kindred with Multiple Endocrine Neoplasia Type IIA Associated with Cutaneous Lichen Amyloidosis
2002
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
A Preoperative Nomogram for the Prediction of Ipsilateral Central Compartment Lymph Node Metastases in Papillary Thyroid Cancer
2013
RET Proto-Oncogene in Sardinia: V804M Is the Most Frequent Mutation and May Be Associated with FMTC/MEN-2A Phenotype
2007
Ectopic Adrenocorticotropic Hormone-Syndrome in Medullary Carcinoma of the Thyroid: A Retrospective Analysis and Review of the Literature
2005
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
Papillary Thyroid Carcinoma in Patients with RET Proto-Oncogene Germline Mutation
2002
Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma
2015
Cancer Therapy with Radiolabeled and Drug/Toxin-conjugated Antibodies
2005
Prophylactic Surgery for Multiple Endocrine Neoplasia Type IIa after Genetic Diagnosis: Is Parathyroid Transplantation Indicated?
1996
Screening of six risk exons of the RET proto-oncogene in families with medullary thyroid carcinoma in the Czech Republic
2004
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors
2006
Pattern of Nodal Metastasis for Primary and Reoperative Thyroid Cancer
2001
Prospective Trial of Unilateral Surgery for Nonhereditary Medullary Thyroid Carcinoma in Patients without Germline RET Mutations
2002
ImageJ for Microscopy
2007 Standout
American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis
2004
Medullary Thyroid Carcinoma
1998
Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Treated with Anticarcinoembryonic Antigen-Targeted Radioimmunotherapy
2007
von Hippel-Lindau Disease
2006 StandoutNobel
RET Is Constitutively Activated by Novel Tandem Mutations that Alter the Active Site Resulting in Multiple Endocrine Neoplasia Type 2B
2006
Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft.
2002
Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.
2006
Familial Medullary Thyroid Carcinoma: Clinical Variability and Low Aggressiveness Associated withRETMutation at Codon 804
2002
Thyroid Microcarcinoma: Fine-Needle Aspiration Diagnosis and Histologic Follow-up
2002
The adrenal gland: an evolution of the roles of genetic counsellors and medical geneticists in endocrine cancers
2016
Risk and Penetrance of Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A Families with Mutations at Codon 634 of the RET Proto-Oncogene
1998
High prevalence of the C634Y mutation in the RET proto-oncogene in MEN 2A families in Spain
1999
Medullary thyroid cancer diagnosis: An appraisal
2013
Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients
2006
A Novel 9-Base Pair Duplication in RET Exon 8 in Familial Medullary Thyroid Carcinoma1
1999
Estimation of Risk of Inherited Medullary Thyroid Carcinoma in Apparent Sporadic Patients
2001
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis
1996
Role of prophylactic thyroidectomy in RET 790 familial medullary thyroid carcinoma
2011
Review of Multiple Endocrine Neoplasia Type 2A in Children: Therapeutic Results of Early Thyroidectomy and Prognostic Value of Codon Analysis
2003
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
A phase I trial combining high-dose 90Y-labeled humanized anti-CEA monoclonal antibody with doxorubicin and peripheral blood stem cell rescue in advanced medullary thyroid cancer.
2005
Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma.
1996
Cancer treatment and survivorship statistics, 2019
2019 Standout
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group
2006
Increased Risk of Lymph Node Metastasis in Multifocal Hereditary and Sporadic Medullary Thyroid Cancer
2007
Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
1995
Guidelines for the management of thyroid cancer
2014 Standout
Improved Tumor Selectivity of Radiolabeled Peptides by Receptor and Antigen Dual Targeting in the Neurotensin Receptor Model
2002
Adrenocortical Carcinoma
2013
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
2016 Standout
RET Proto-Oncogene in the Development of Human Cancer
1999
Imaging Medullary Thyroid Carcinoma with Persistent Elevated Calcitonin Levels
2007
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
Inhaled insulin1Abbreviations: DM, diabetes mellitus; AIDs, acquired immune deficiency syndrome; SC, subcutaneous; DCCT, Diabetes Control and Complications Trial; IDDM, insulin-dependent diabetes mellitus; NIDDM, non-insulin-dependent diabetes mellitus; i.v., intravenous; DDPC, di-decanoyl-alpha-phosphatidylcholine; AUC, area under the curve; INH, inhaled; Cmax, maximum serum concentration; Cmin, minimum serum concentration; Tmax, time of maximum serum concentration; NS, not significant; HbA1c, hemoglobin A1c; OA, oral agent; SD, standard deviation; MDI, metered dose inhaler; DPI, dry powder inhaler; MMAD, mass median aerodynamic diameter; CMC, critical micelle concentration; SR, sustained release; PLGA, poly lactic acid-co-glycolic acid; GI, gastrointestinal, GSD, geometric standard deviation; TLC, total lung capacity; VC, vital capacity; SMK, smokers; MW, molecular weight; MP, melting point.1
1999
Thyroid carcinoma
2003 Standout
Rapid, nonradioactive screening for mutations in exons 10, 11, and 16 of the RET protooncogene associated with inherited medullary thyroid carcinoma
1997
Works of A. Murat being referenced
Prognostic Factors of Disease-Free Survival after Thyroidectomy in 170 Young Patients with a RET Germline Mutation: A Multicenter Study of the Groupe Français d'Etude des Tumeurs Endocrines
2010
[Detection of residual lesions and metastases of medullary thyroid cancer].
1996
Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC)
1999
High Frequency of Bone/Bone Marrow Involvement in Advanced Medullary Thyroid Cancer
2005
Predictive factors for node involvement in papillary thyroid carcinoma. Univariate and multivariate analyses
1999
Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'étude des Tumeurs Endocrines database
2011
Improvement of blood glucose control in Type 1 diabetic patients treated with lispro and multiple NPH injections
1999
Inter- and intrasubject variability of solid and liquid gastric emptying parameters
1994
Sporadic Medullary Microcarcinoma of the Thyroid: A Retrospective Analysis of Eighty Cases
1998
Les gastrinomes dans les néoplasies endocriniennes multiples de type 1. Une étude de cohorte de 127 cas du groupe des tumeurs endocrines (GTE)
2004
Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma
2001
Gastric emptying improvement after simultaneous segmental pancreas and kidney transplantation.
1992
Influence of concentration on the kinetics of SC-infused insulin. Comparison between square-wave SC infusion and bolus SC injection
1985
[Outcome in cervical recurrences of papillary or follicular thyroid cancer].
1999
[Early therapeutic management of patients genetically predisposed to medullary thyroid cancer].
1998
Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I/II clinical trial.
1999
[Prognostic factors of survival without clinical recurrences in medullary thyroid carcinoma: apropos of 52 operated cases].
1999
Is cyclosporine toxic for human pancreas?
1988
RET mutations in exons 13 and 14 of FMTC patients.
1995
Definitive corticosteroid withdrawal following simultaneous pancreas and kidney transplantation.
1991
Normal glucose metabolism and insulin secretion in CyA-treated nondiabetic renal allograft patients not receiving steroids.
1990